Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Solid Biosciences Inc. from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Solid Biosciences Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2018 to Q4 2024.
  • Solid Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was $4.36M, a 2.95% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Solid Biosciences Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $4.36M +$125K +2.95% 31 Dec 2024 10-K 06 Mar 2025
Q4 2023 $4.24M +$121K +2.94% 31 Dec 2023 10-K 13 Mar 2024
Q4 2022 $4.12M 31 Dec 2022 10-K 23 Mar 2023
Q4 2020 $419K -$267K -38.9% 31 Dec 2020 10-K 15 Mar 2021
Q4 2019 $686K -$337K -32.9% 31 Dec 2019 10-K 12 Mar 2020
Q3 2019 $1.42M 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $1.42M 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $1.42M 31 Mar 2019 10-Q 13 May 2019
Q4 2018 $1.02M 31 Dec 2018 10-Q 14 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.